Drugs / Hyaluronic Acid Gel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01738243 | Dec 2013 → Sep 2021 | disease of orbital part of eye adnexa | University of California, Los Angeles | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hyaluronic Acid Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01738243 ↗ |
| Known as | HAG | “Hyaluronic Acid Gels (HAG) have been FDA approved for the treatment of facial rhytids (wrinkles).” NCT01738243 ↗ |